Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infections in infants and young children. There are no licensed RSV vaccines available, and the few treatment options for high-risk individuals are either extremely costly or cause severe side effects and toxicit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Martinez, Elisa C., Garg, Ravendra, Shrivastava, Pratima, Gomis, Susantha, van Drunen Littel-van den Hurk, Sylvia
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7126411/
https://ncbi.nlm.nih.gov/pubmed/27771388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.10.008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados